Genetics in the Progression of Nephropathies

ConditionsAKI CKD Ckd-Mbd CKD (Chronic Kidney Disease) Stage 5D ADPKD Hypertension Hematologic Malignancy Bone Marrow Transplant Complications

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorOspedale San Raffaele

About this trial

This study evaluates the role of genetic in the development and progression of different nephropaties with particular attention to:

* AKI * CKD * Hypertension * ADPKD * CKD-MBD * Patients with decompensated heart failure undergoing either medical or surgery therapy * Patients with hematologic cancer exposed to chemotherapeutic agents or undergoing allogeneic bone marrow transplantation * glomerular diseases

Eligibility criteria

Qualifiers

None

Disqualifiers

to be evaluated in the different sub-protocols

Trial design

Treatments tested in this trial

genetic polymorphisms

Treatment groups

10,000 Participants

are divided into 1 treatment group

Sponsors and collaborators

Ospedale San Raffaele

Lead sponsor

Source ClinicalTrials.gov